The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients

Hilbert W van der Glas, Robert J van Grootel

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Abstract

    Treatment duration varies with the type of therapy and a patient's recovery speed. Including such a variation in randomized controlled trials (RCTs) enables comparison of the actual therapeutic potential of different therapies in clinical care. An index, Treatment Duration Control (TDC) of outcome scores was developed to help decide when to end treatment and also to determine treatment outcome by a blinded assessor. In contrast to traditional Routine Outcome Monitoring which considers raw score changes, TDC uses relative change.
    Original languageEnglish
    Pages (from-to)123
    JournalBMC Medical Research Methodology
    Volume13
    DOIs
    Publication statusPublished - 2013

    Keywords

    • Arthralgia
    • Chronic Pain
    • Clinical Protocols
    • Humans
    • Long-Term Care
    • Pain Measurement
    • Quality of Life
    • Randomized Controlled Trials as Topic
    • Temporomandibular Joint Disorders
    • Treatment Outcome

    Fingerprint

    Dive into the research topics of 'The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients'. Together they form a unique fingerprint.

    Cite this